![David Woodhouse](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Woodhouse
Président chez
SURROZEN, INC.
Fortune : 61 358 $ au 31/05/2026
Profil
David J.
Woodhouse is currently Chief Executive Officer & Director at Nuvig Therapeutics, Inc. since 2025.
He is Chairman at Surrozen, Inc. since 2023 and Director at Surrozen Operating, Inc. since 2020.
Formerly, Dr. Woodhouse was Managing Director at Goldman Sachs & Co. LLC from 2002 to 2015.
He was Chief Executive & Financial Officer, Director at NGM Biopharmaceuticals, Inc. from 2018 to 2020.
He also worked as a Research Assistant at Amgen, Inc. Education includes undergraduate studies at the University of California, Santa Barbara, an MBA from Tuck School of Business at Dartmouth, and a doctorate from Stanford University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SURROZEN INC 0,02 % | 13/05/2026 | 2 341 ( 0,02 % ) | 61 358 $ | 31/05/2026 |
Postes actifs de David Woodhouse
| Sociétés | Poste | Début |
|---|---|---|
| SURROZEN, INC. | Président | 01/04/2023 |
Surrozen Operating, Inc.
 Surrozen Operating, Inc. BiotechnologyHealth Technology Discovers and develops novel regenerative medicines | Directeur/Membre du Conseil | 25/09/2020 |
Nuvig Therapeutics, Inc.
 Nuvig Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops translating novel therapeutics medicine for autoimmune diseases | Directeur Général | 09/09/2025 |
Anciens postes connus de David Woodhouse
| Sociétés | Poste | Fin |
|---|---|---|
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01/01/2015 |
| AMGEN INC. | Corporate Officer/Principal | - |
| NGM BIOPHARMACEUTICALS, INC. | Directeur Général | - |
Formation de David Woodhouse
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
97
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
NGM Biopharmaceuticals, Inc.
 NGM Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel & life-changing medicines | Health Technology |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of California, Santa Barbara
 University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tuck School of Business at Dartmouth
 Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University School of Medicine
 Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Surrozen Operating, Inc.
Surrozen Operating, Inc. BiotechnologyHealth Technology Discovers and develops novel regenerative medicines | Health Technology |
Surrozen, Inc.
 Surrozen, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that discovering and developing drug candidates | Health Technology |
Nuvig Therapeutics, Inc.
Nuvig Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops translating novel therapeutics medicine for autoimmune diseases | Health Technology |
Choisissez Zonebourse 
